CA2 and colon adenocarcinoma: A previous study [24] conducted integrated bioinformatics analysis has found that lower expression of CA2 had a shorter overall survival compared to those with higher expression in COAD patients, its RNA and protein expression level were also validated in TCGA and the Human Protein Atlas, but without any experimental validation.